Profound Medical Corp. (PROF) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Profound Medical Corp. (PROF:NASDAQ), powered by AI.

Current Price
$6.63
Sector
Healthcare
What is the Profound Medical Corp. stock price forecast?

Profound Medical Corp. is currently trading at $6.63. View real-time AI analysis on Alpha Lenz.

What is Profound Medical Corp. insider trading activity?

View the latest insider trading data for Profound Medical Corp. on Alpha Lenz.

What is Profound Medical Corp.'s P/E ratio?

View Profound Medical Corp.'s valuation metrics on Alpha Lenz.

Profound Medical Corp.

NASDAQ · PROF
$6.63-0.03(-0.38%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Profound Medical Corp.'s future dividend policy...
Alpha Chat Insight

Profound Medical Corp.'s ROE is -67.1%. Explore profitability and growth together.

Ask for details

Company Overview

Profound Medical Corp. is a pioneering company in the medical technology sector, specializing in the development of innovative therapeutic platforms for treating prostate issues, breast cancer, and uterine fibroids. The core function of Profound Medical Corp. is to provide minimally invasive therapeutic solutions, leveraging its proprietary technologies to improve patient outcomes and enhance the efficacy of treatments. The company's proprietary TULSA-PRO and SONALLEVE systems integrate ultrasound imaging with precise ablation capabilities, offering non-invasive options for patients. These technologies are particularly significant in the healthcare sector as they aim to reduce recovery time, lower the risk of complications, and improve overall treatment experiences. By focusing on areas such as oncology and men’s health, Profound Medical Corp. plays a crucial role in advancing medical treatments and improving the quality of life for patients. The company's innovations are poised to impact hospitals, clinics, and specialized medical facilities globally, marking a significant advancement in non-surgical therapeutic strategies."

CEODr. Arun Swarup Menawat MBA, Ph.D.
SectorHealthcare
IndustryMedical Devices
Employees142

Company Statistics

FY 2025

Profile

N/AMarket Cap
$16.10MRevenue
0.00Shares Out
142Employees

Margins

70.77%Gross
-239.53%EBITDA
-256.27%Operating
-262.88%Pre-Tax
-264.44%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

34.06%Rev 3Yr
17.12%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-57.64%ROA
-67.12%ROE
-55.86%ROIC

Financial Health

$59.72MCash & Cash Equivalents
$-48.68MNet Debt
16.62%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Profound Medical Corp. (ticker: PROF) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 142 employees.

The current price is $6.625 with a P/E ratio of -x and P/B of -x.

ROE is -67.12% and operating margin is -256.27%. Annual revenue is $16M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Profound Medical Corp. (PROF) Stock Forecast 2026 $6.63 — Price, Financials & Analyst Targets | Alpha Lenz